Cardio Diagnostics Holdings, Inc. – NASDAQ:CDIO

Add to watchlist

$3.65

+2.72

+294.59%

Market closed

Open in about 2 hours

+68.80%

month

+68.80%

quarter

-62.24%

year

Market Cap	41.26M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-0.81

Revenue	32.99K
EBITDA	-9.54M
Income	-11.50M
Revenue Q/Q	N/A
Revenue Y/Y	3372.94%

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	-28938.19%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO): Profit margin
Jun 2023	1.72K	-4.02M	-233211.88%
Sep 2023	10.03K	-1.93M	-19266.02%
Dec 2023	5.31K	-1.38M	-26156.85%
Mar 2024	15.92K	-4.16M	-26140.03%

Cardio Diagnostics Holdings Financials Estimate

Q Y

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO): Analyst Estimates
Sep 2025	450K	-1.64M	-365.16%
Oct 2025	450K	-1.89M	-421.54%
Dec 2025	4M	-2.73M	-68.45%
Dec 2025	1M	-1.89M	-189.69%

Analysts Price target
Financials & Ratios estimates

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO): Earnings per share (EPS)
2024-04-01	-0.13	-0.06762
2024-07-01	-0.13	-0.2

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO): Debt to assets
Jun 2023	6756904	3.84M	56.95%
Sep 2023	5963307	3.67M	61.64%
Dec 2023	4462365	1.50M	33.71%
Mar 2024	4327563	1.29M	29.83%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO): Cash Flow
Jun 2023	-1.29M	-87.59K	-283.01K
Sep 2023	-1.04M	-87.07K	-283.01K
Dec 2023	-1.68M	-566.94K	-93.5K
Mar 2024	-1.23M	-69.94K	1.58M

Cardio Diagnostics Holdings alternative data

Cardio Diagnostics Holdings
Employees

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO): Employee count
Aug 2023	7
Sep 2023	7
Oct 2023	7
Nov 2023	7
Dec 2023	7
Jan 2024	7
Feb 2024	7
Mar 2024	7
Apr 2024	7
May 2024	7
Jun 2024	7
Jul 2024	7

Cardio Diagnostics Holdings
Hedge Funds Holdings Q1 2023

0.93% -18.74%

of CDIO is owned by hedge funds

6 -6

hedge funds hold CDIO stock

28.66K -200.17K

shares is hold by hedge funds

CDIO hedge funds holdings changes

Cardio Diagnostics Holdings
Insider Trading

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO): Insider trades (number of shares)
Period	Buy	Sel
Aug 2023	66962	0
Sep 2023	0	0
Dec 2023	0	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	31 Mar 2024	BURTON PAUL FREDERICK director director	Common Stock	8,803	$1.42	$12,500
Option	31 Mar 2024	BURTON PAUL FREDERICK director director	Restricted Stock Units	0	N/A	N/A
Option	31 Mar 2024	LAU STANLEY K. director director	Common Stock	8,803	$1.42	$12,500
Option	31 Mar 2024	LAU STANLEY K. director director	Restricted Stock Units	0	N/A	N/A
Option	31 Mar 2024	INTRATER JAMES director director	Common Stock	8,803	$1.42	$12,500
Option	31 Mar 2024	INTRATER JAMES director director	Restricted Stock Units	0	N/A	N/A
Option	31 Mar 2024	LEVY ODED director director	Common Stock	8,803	$1.42	$12,500
Option	31 Mar 2024	LEVY ODED director director	Restricted Stock Units	0	N/A	N/A
Option	31 Jan 2024	LAU STANLEY K. director director	Common Stock	917	$2.18	$1,999
Option	31 Jan 2024	LAU STANLEY K. director director	Restricted Stock Units	0	N/A	N/A

CDIO insider trading transactions

Cardio Diagnostics Holdings
Latest News

Monday, 16 December 2024
08:31	Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests	businesswire.com
Tuesday, 1 October 2024
08:31	Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests	businesswire.com
Tuesday, 25 June 2024
08:31	Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum	businesswire.com
Monday, 10 June 2024
08:31	Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality	businesswire.com
Tuesday, 21 May 2024
08:31	Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests	businesswire.com
Monday, 20 May 2024
01:03	Reviewing ARCA biopharma (NASDAQ:ABIO) and Cardio Diagnostics (NASDAQ:CDIO)	https://www.defenseworld.net
Monday, 13 May 2024
08:31	Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week	businesswire.com
Monday, 29 April 2024
08:31	Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually	businesswire.com
Tuesday, 9 April 2024
08:31	Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan	businesswire.com
Thursday, 4 April 2024
08:31	Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre	businesswire.com
Thursday, 14 March 2024
08:31	Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific Session	businesswire.com
Tuesday, 5 March 2024
08:31	Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease	businesswire.com
Thursday, 15 February 2024
08:46	Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout	businesswire.com
Wednesday, 7 February 2024
08:31	Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters	businesswire.com
Monday, 5 February 2024
08:31	Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests	businesswire.com
Wednesday, 24 January 2024
08:31	Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor	businesswire.com
Monday, 8 January 2024
08:31	Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India	businesswire.com
Thursday, 4 January 2024
11:36	CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™	businesswire.com
08:31	Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™	businesswire.com
Wednesday, 3 January 2024
08:31	American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event	businesswire.com
Tuesday, 2 January 2024
08:31	American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.'s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code	businesswire.com
Wednesday, 6 December 2023
08:31	Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement	businesswire.com
Monday, 4 December 2023
17:38	CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference	businesswire.com
08:31	Cardio Diagnostics Holdings, Inc's Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference	businesswire.com
Tuesday, 28 November 2023
08:31	American Medical Association is Reviewing Cardio Diagnostics Holdings, Inc's Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes	businesswire.com
Monday, 20 November 2023
11:53	Cardio Diagnostics shares rocket on validation of coronary heart disease detection test	Proactive Investors
Tuesday, 31 October 2023
15:56	Why Is Cardio Diagnostics (CDIO) Stock Up 45% Today?	InvestorPlace

Frequently Asked Questions (FAQ)

What's the price of Cardio Diagnostics Holdings stock today?

One share of Cardio Diagnostics Holdings stock can currently be purchased for approximately $3.65.
When is Cardio Diagnostics Holdings's next earnings date?

Unfortunately, Cardio Diagnostics Holdings's (CDIO) next earnings date is currently unknown.
Does Cardio Diagnostics Holdings pay dividends?

No, Cardio Diagnostics Holdings does not pay dividends.
How much money does Cardio Diagnostics Holdings make?

Cardio Diagnostics Holdings has a market capitalization of 41.26M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1696.32% to 17.07K US dollars. Cardio Diagnostics Holdings made a loss 8.38M US dollars in net income (profit) last year or -$0.2 on an earnings per share basis.
What is Cardio Diagnostics Holdings's stock symbol?

Cardio Diagnostics Holdings, Inc. is traded on the NASDAQ under the ticker symbol "CDIO".
What is Cardio Diagnostics Holdings's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Cardio Diagnostics Holdings?

Shares of Cardio Diagnostics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Cardio Diagnostics Holdings have?

As Jul 2024, Cardio Diagnostics Holdings employs 7 workers.
When Cardio Diagnostics Holdings went public?

Cardio Diagnostics Holdings, Inc. is publicly traded company for more then 3 years since IPO on 14 Jan 2022.
What is Cardio Diagnostics Holdings's official website?

The official website for Cardio Diagnostics Holdings is cardiodiagnosticsinc.com.
Where are Cardio Diagnostics Holdings's headquarters?

Cardio Diagnostics Holdings is headquartered at 400 N Aberdeen St, Chicago, IL.
How can i contact Cardio Diagnostics Holdings?

Cardio Diagnostics Holdings's mailing address is 400 N Aberdeen St, Chicago, IL and company can be reached via phone at +855 2269991.

Cardio Diagnostics Holdings, Inc.

cardiodiagnosticsinc.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

+855 2269991

400 N Aberdeen St
Chicago, IL 60642

CIK: 0001870144
ISIN: US14159C1036
CUSIP: 14159C103